Uterine artery embolization for treatment of symptomatic uterine fibroids

BlueCross BlueShield Association
Record ID 32003000757
Authors' objectives:

This Assessment examines the risks and benefits of uterine artery embolization (UAE) as a treatment for symptomatic uterine leiomyomata, also known as uterine fibroids.

Authors' methods: Systematic review
Project Status: Completed
Year Published: 2002
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Embolization, Therapeutic
  • Leiomyoma
  • Uterine Neoplasms
  • Uterus
Organisation Name: BlueCross BlueShield Association
Contact Address: BlueCross BlueShield Association, Technology Evaluation Center, 225 North Michigan Ave, Chicago, Illinois, USA. Tel: 888 832 4321
Contact Name: tec@bcbsa.com
Contact Email: tec@bcbsa.com
Copyright: BlueCross BlueShield Association (BCBS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.